South African biopharmaceutical manufacturer Biovac has entered into a memorandum of understanding (MOU) with Korea-based vaccine manufacturer EuBiologics to facilitate the technology transfer of a meningococcal meningitis pentavalent vaccine. This collaborative effort is driven by the need to combat the prevalence of meningococcal disease in sub-Saharan Africa, particularly in the “meningitis belt” that stretches from … Continue reading Biovac, EuBiologics partner to create meningitis vaccine in Africa